Phase 1 Active Ulcerative Colitis Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Superdonor FMT in Patients With Ulcerative Colitis
Active Ulcerative Colitis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS42 enrolled1 locationNCT05739864
Recruiting
Phase 1
A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis
Active Ulcerative ColitisActive Ulcerative Colitis (UC)Healthy Adult Volunteers
NIBEC Co., Ltd.24 enrolled1 locationNCT06681389
Not Yet Recruiting
Phase 1
The Pharmacokinetics and the Effect of Extended-release Thioguanine Tablets on Symptoms in Adults with Ulcerative Colitis.
Inflammatory Bowel DiseaseActive Ulcerative Colitis
Douglas Pharmaceuticals12 enrolled1 locationACTRN12624001448538
Recruiting
Phase 1
Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
Active Ulcerative Colitis (UC)
The University of Texas Health Science Center, Houston20 enrolled1 locationNCT05786404